NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 251 filers reported holding NOVAVAX INC in Q3 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $725,551 | -21.3% | 100,214 | -24.7% | 0.00% | – |
Q2 2023 | $922,273 | 0.0% | 133,084 | 0.0% | 0.00% | – |
Q1 2023 | $922,273 | -9.8% | 133,084 | +33.8% | 0.00% | -100.0% |
Q4 2022 | $1,022,160 | -99.9% | 99,432 | +0.4% | 0.00% | 0.0% |
Q3 2022 | $1,803,328,000 | -70.1% | 99,084 | -15.5% | 0.00% | -66.7% |
Q2 2022 | $6,027,853,000 | -62.8% | 117,205 | -46.7% | 0.00% | -57.1% |
Q1 2022 | $16,200,568,000 | -48.3% | 219,967 | +0.4% | 0.01% | -41.7% |
Q4 2021 | $31,339,770,000 | -31.4% | 219,052 | -0.6% | 0.01% | -36.8% |
Q3 2021 | $45,684,905,000 | -27.2% | 220,370 | -25.5% | 0.02% | -29.6% |
Q2 2021 | $62,776,457,000 | +101.4% | 295,683 | +72.0% | 0.03% | +92.9% |
Q1 2021 | $31,171,540,000 | +35.2% | 171,924 | -16.8% | 0.01% | +27.3% |
Q4 2020 | $23,050,903,000 | +26.2% | 206,716 | +22.7% | 0.01% | +10.0% |
Q3 2020 | $18,260,335,000 | +372.2% | 168,531 | +263.2% | 0.01% | +400.0% |
Q2 2020 | $3,867,107,000 | +3724.7% | 46,396 | +130.4% | 0.00% | – |
Q3 2019 | $101,108,000 | +11.3% | 20,141 | +29.9% | 0.00% | – |
Q2 2019 | $90,859,000 | – | 15,505 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 90,000 | $4,629,000 | 1.95% |
Affinity Asset Advisors, LLC | 85,000 | $4,372,000 | 1.84% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,814 | $132,500,000 | 1.38% |
Mendel Capital Management LLC | 23,835 | $1,226,000 | 1.37% |
Faithward Advisors, LLC | 80,143 | $4,122,000 | 0.92% |
Coatue Management | 1,241,716 | $63,861,000 | 0.77% |
Rock Springs Capital Management LP | 475,100 | $24,434,000 | 0.71% |
SECTOR GAMMA AS | 55,324 | $2,845,000 | 0.64% |
SevenOneSeven Capital Management | 5,103 | $262,000 | 0.61% |
SECTORAL ASSET MANAGEMENT INC | 49,200 | $2,530,000 | 0.51% |